Literature DB >> 14609593

Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States.

Hiroaki Kitaoka1, Yoshinori Doi, Susan A Casey, Nobuhiko Hitomi, Takashi Furuno, Barry J Maron.   

Abstract

The morphologic apical form of hypertrophic cardiomyopathy (HC), in which left ventricular (LV) wall thickening is confined to the most distal region at the apex, has been regarded as a phenotypic expression of nonobstructive HC largely unique to Japanese patients. To investigate this question further, we directly compared unselected and regional hospital-based cohorts of adult patients with HC ( > or =18 years of age) from Japan (Kochi; n=100) and from the United States (US) (Minneapolis; n=361). Japanese and American patients with HC had similar clinical features and did not differ significantly with regard to the severity of symptoms and frequency of outflow obstruction. Although Japanese and American patients also showed similar maximum LV thickness, they differed significantly with respect to the distribution of LV hypertrophy. In particular, the segmental form of HC, with hypertrophy confined to the LV apex, was more frequent in Japanese patients (i.e., apical HC, 15% in Japan vs 3% in US, p<0.0001). Giant negative T waves were also more common in Japanese patients with HC (26% vs 2%, p<0.001), including those with the apical form (64% vs. 30%, p<0.05). Each patient with apical HC had either no or only mild symptoms, and all survived. The morphologic form of nonobstructive HC with hypertrophy limited to the LV apex (apical form of HC) was 5 times more common in an unselected Japanese population. These findings document variability in the phenotypic expression of HC between countries and races, which may be due to differences in environmental factors or genetic background. Patients with the apical form of HC had a benign clinical course.

Entities:  

Mesh:

Year:  2003        PMID: 14609593     DOI: 10.1016/j.amjcard.2003.07.027

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  49 in total

1.  MRI classification of asymmetric septal hypertrophic cardiomyopathy and its relation to the presence of risk factors.

Authors:  Yasuo Amano; Mitsunobu Kitamura; Morimasa Takayama; Masaki Tachi; Shinichiro Kumita
Journal:  Int J Cardiovasc Imaging       Date:  2012-03-04       Impact factor: 2.357

2.  Apical hypertrophic cardiomyopathy presenting as recurrent unexplained syncope.

Authors:  Yusuf Kasirye; Janaki Ram Manne; Narendranath Epperla; Sowjanya Bapani; Romel Garcia-Montilla
Journal:  Clin Med Res       Date:  2011-08-04

3.  The missing spade: apical hypertrophic cardiomyopathy investigation.

Authors:  F Alpendurada; S K Prasad
Journal:  Int J Cardiovasc Imaging       Date:  2008-07-02       Impact factor: 2.357

4.  Myocardial perfusion image findings in apical hypertrophic cardiomyopathy.

Authors:  Bill P C Hsieh; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2012-02       Impact factor: 5.952

5.  Yamaguchi syndrome presenting as atrioventricular nodal re-entrant tachycardia in an African-American patient.

Authors:  Nellowe Candelario; Jorge Penalver; Mitali Sen
Journal:  BMJ Case Rep       Date:  2017-02-06

6.  Idiopathic Isolated Right Ventricular Apical Hypertrophy.

Authors:  Debika Chatterjee; Pradeep Narayan
Journal:  Acta Cardiol Sin       Date:  2018-05       Impact factor: 2.672

Review 7.  Apical variant hypertrophic cardiomyopathy "multimodality imaging evaluation".

Authors:  Gary Huang; Shaimaa A Fadl; Stan Sukhotski; Manuela Matesan
Journal:  Int J Cardiovasc Imaging       Date:  2019-12-18       Impact factor: 2.357

8.  Apical hypertrophic cardiomyopathy.

Authors:  Raymond F Stainback
Journal:  Tex Heart Inst J       Date:  2012

9.  Incidental diagnosis of apical hypertrophic cardiomyopathy in an 18-year-old white man.

Authors:  Amyn Malik
Journal:  Tex Heart Inst J       Date:  2012

10.  Apical hypertrophic cardiomyopathy.

Authors:  Syed Wamique Yusuf; Jaya D Bathina; Jose Banchs; Elie N Mouhayar; Iyad N Daher
Journal:  World J Cardiol       Date:  2011-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.